GEHC
NASDAQHealthcareLoading…
GE HealthCare Technologies Inc. - Common Stock
Sector: Healthcare•United States•Market Cap: $32.9B
Related News
Latest stories connected to GEHC
- RS 78Warren Davidson Sells Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)Financial Modeling Prep•1d ago•Original source
- RS 78Here's Why You Should Retain GEHC Stock in Your Portfolio for NowZacks Investment Research•3d ago•Original source
- RS 78GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging CapabilitiesZacks Investment Research•Mar 20, 2026•Original source
- RS 78GEHC & Springbok Collaborate on MRI Muscle Analysis for SportsZacks Investment Research•Mar 19, 2026•Original source
- RS 78GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision careBusiness Wire•Mar 18, 2026•Original source
- RS 78GEHC vs. ABT: Which Stock Is the Better Value Option?Zacks Investment Research•Mar 16, 2026•Original source
- RS 78After Plunging 8.3% in 4 Weeks, Here's Why the Trend Might Reverse for GE HealthCare (GEHC)Zacks Investment Research•Mar 12, 2026•Original source
- RS 78GE HealthCare Technologies Inc. (GEHC) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha•Mar 10, 2026•Original source
- RS 78Why GE HealthCare Technologies (GEHC) is a Top Momentum Stock for the Long-TermZacks Investment Research•Mar 3, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Revenue | 20.63B | 19.67B | 19.55B | 18.34B | 17.59B | 17.16B | 16.63B |
| Cost of Revenue | 12.38B | 11.47B | 11.63B | 11.16B | 10.41B | 10.40B | 10.09B |
| Gross Profit | 8.25B | 8.21B | 7.92B | 7.18B | 7.17B | 6.77B | 6.55B |
| Research and Development Expenses | 1.26B | 1.31B | 1.21B | 1.03B | 816.00M | 810.00M | 833.00M |
| General and Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling and Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 4.22B | 4.27B | 4.28B | 3.63B | 3.56B | 3.24B | 3.59B |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 5.49B | 5.58B | 5.49B | 4.66B | 4.38B | 4.05B | 4.42B |
| Cost and Expenses | 17.86B | 17.05B | 17.12B | 15.82B | 14.79B | 14.44B | 14.51B |
| Net Interest Income | -450.00M | -505.00M | -516.00M | -86.00M | -6.00M | -17.00M | -52.00M |
| Interest Income | 0 | 0 | 26.00M | 0 | 34.00M | 49.00M | 36.00M |
| Interest Expense | 450.00M | 505.00M | 542.00M | 86.00M | 40.00M | 66.00M | 88.00M |
| Depreciation and Amortization | 578.00M | 580.00M | 610.00M | 633.00M | 625.00M | 630.00M | 659.00M |
| EBITDA | 3.79B | 3.67B | 3.51B | 3.17B | 3.54B | 3.41B | 2.84B |
| EBIT | 3.21B | 3.09B | 2.90B | 2.53B | 2.92B | 2.78B | 2.18B |
| Non Operating Income Excluding Interest | -445.00M | -461.00M | -468.00M | -10.00M | -120.00M | -56.00M | -55.00M |
| Operating Income | 2.76B | 2.63B | 2.44B | 2.52B | 2.79B | 2.72B | 2.12B |
| Total Other Income Expenses Net | 6.00M | -44.00M | -74.00M | -10.00M | 80.00M | -10.00M | -33.00M |
| Income Before Tax | 2.77B | 2.58B | 2.36B | 2.51B | 2.88B | 2.71B | 2.09B |
| Income Tax Expense | 614.00M | 531.00M | 743.00M | 563.00M | 600.00M | 652.00M | 410.00M |
| Net Income From Continuing Operations | 2.15B | 2.05B | 1.62B | 1.95B | 2.27B | 2.06B | 1.68B |
| Net Income From Discontinued Operations | 0 | 0 | -4.00M | 18.00M | 18.00M | 11.84B | -128.00M |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 2.15B | 2.05B | 1.62B | 1.95B | 2.27B | 2.06B | 1.68B |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — |
| EPS | 4.56 | 4.37 | 3.04 | 4.22 | 4.9 | 4.41 | 3.35 |
| EPS Diluted | 4.55 | 4.34 | 3.02 | 4.22 | 4.9 | 4.41 | 3.35 |
| Weighted Average SHS Out | 456.52M | 456.00M | 455.00M | 453.93M | 454.71M | 454.71M | 454.71M |
| Weighted Average SHS Out Dil | 460.27M | 459.00M | 458.00M | 453.93M | 454.71M | 454.71M | 454.71M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.4 | 0.42 | 0.41 | 0.39 | 0.41 | 0.39 | 0.39 |
| R&D to Revenue | 0.06 | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 |
| SG&A to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Burden | 0.86 | 0.84 | 0.81 | 0.99 | 0.99 | 0.98 | 0.96 |
| EBIT Margin | 0.16 | 0.16 | 0.15 | 0.14 | 0.17 | 0.16 | 0.13 |
| EBITDA Margin | 0.18 | 0.19 | 0.18 | 0.17 | 0.2 | 0.2 | 0.17 |
| EBT per EBIT | 1 | 0.98 | 0.97 | 1 | 1.03 | 1 | 0.98 |
| Effective Tax Rate | 0.22 | 0.21 | 0.31 | 0.22 | 0.21 | 0.24 | 0.2 |
| Tax Burden | 0.75 | 0.77 | 0.66 | 0.76 | 0.78 | 5.11 | 0.73 |
| Cont. Operations Profit Margin | 0.1 | 0.1 | 0.08 | 0.11 | 0.13 | 0.12 | 0.1 |
| Bottom Line Profit Margin | 0.1 | 0.1 | 0.07 | 0.1 | 0.13 | 0.12 | 0.09 |
| Operating Cycle | 135.87 | 142.91 | 142.07 | 149.93 | 146.91 | 112.46 | 0 |
| Fwd PEG Ratio | 4.13 | 0.41 | -0.8 | -1 | 1.09 | 0.06 | 0 |
| Earnings Yield | 0.06 | 0.06 | 0.04 | 0.07 | 0.08 | 0.51 | 0.06 |
| Income Quality | 0.92 | 0.95 | 1.3 | 1.08 | 0.71 | 0.82 | 1.18 |